Biohaven Pharmaceuticals
Jennifer Laakso, CPA, is an experienced accounting professional with a strong background in SEC reporting and technical accounting. Currently serving as the Director of SEC Reporting & Technical Accounting at Biohaven since September 2021, Jennifer previously held the role of Associate Director in the same field. Prior to Biohaven, Jennifer worked at Citizens Bank as VP, Corporate Reporting Senior Analyst, and at LoJack Corporation as SEC Reporting Manager and Senior SEC Accountant. Jennifer began the career at KPMG, where roles included Senior Associate and Audit Associate. Jennifer holds a Bachelor of Science in Accounting from the University of Rhode Island, earned in 2007.
This person is not in any teams
This person is not in any offices
Biohaven Pharmaceuticals
6 followers
Biohaven is engaged in the identification and development of clinical stage compounds targeting the glutamatergic system.